Understanding the Standard: Why Propranolol for Hemangiomas Is a First-Line Treatment
•
4 min read
Affecting up to 5% of infants, infantile hemangiomas are the most common benign tumors of infancy. The discovery of propranolol's effectiveness in 2008 revolutionized treatment, leading to the key question: **why propranolol for hemangiomas?**
